chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709170), concerning a 68-year-old, elderly female patient. The patient's historical condition included: irritable bowel disease, acid reflux, depression, hot flashes. The patient was allergic to doxycycline, Sulfacetamide, sulfa antibiotics, TUSSIONEX and Morphine. On 07-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178502, expiry date: not reported. On the same day, the patient was administered with non-company suspect PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: N010105, expiry date: not reported). About 1 and 1/2 hours after receiving PNEUMOVAX 23, the patient's entire left arm became red, swollen and very sore. The next day, she examined her arm and could find no evidence of redness. Both arms appeared somewhat "puffy" and fingers edematous. It was reported that, the patient's fingers on the left hand appeared slightly more swollen than on right hand. She took TYLENOL and MOTRIN for the pain. Subsequently, the pain was lessened but arm was still somewhat sore. The patient had not yet recovered from all the events (redness, swelling arm, pain in arm, edema fingers, injection site redness, injection site swelling and injection site pain). The reporter assessed the events as non-serious. Non-significant case correction received 06-Mar-2018: Case comment was corrected.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Bedridden, Chills, Contusion, Dizziness, Fall
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709236), concerns a 66-year-old, elderly female patient. The patient's current condition included allergy to intravenous dye. On 17-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178323, expiry date: not reported) and PNEUMOVAX (dose: 1 DF (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: N004564, expiry date: not reported). On the same day, the patient experienced dizziness and chills. It was reported that patient walked into a door, fell and had bruise. The patient was bedridden for 3 days. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious. Significant case correction received with the IRD 06-Mar-2018: The "as determined" causality of the events fall, bedridden and bruise was corrected from related to not related. The case comment was corrected accordingly.
Age: 73.0
Sex: F
Vaccine: FLUA3
Symptoms: Muscle spasms, Muscle twitching, Pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709299), concerns a 73-year-old, elderly, female patient. On 09-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178323, expiry date: not reported). On the same day, after vaccination, patient developed muscle spasm and twitching from shoulder down to elbow particularly while lifting or extending arm. On 21-Aug-2017, the patient had pain with value of 9/10. On the same day, the patient went to urgent care and was prescribed with MEDROL dose pack. At the time of this report, the outcome of events was unknown. The reporter assessed this case as non-serious.
Age: 92.0
Sex: F
Vaccine: FLUA3
Symptoms: Discomfort, Musculoskeletal pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709536), concerns a 92-year-old female patient. The patient's historical conditions included back pain, hypothyroidism. On 17-Aug-2017, the patient was administered with FLUAD (dose: 0.5ml (N/A as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178323). On the same day, after vaccination, the patient had pain in arm and shoulder. The patient complained of discomfort for a week then. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received 06-Mar-2018: The case comment was corrected. No changes were made in narrative.
Age: 66.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709613), concerns a 66-year-old, elderly, male patient. The patient's medical history and current illness was not reported. On 22-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178503 and expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). It was reported that the injections were separated by less than 1 inch apart. On 23-Aug-2017, 1 day after vaccination, the patient left arm from shoulder to elbow was swollen, it also became red, painful and hot around the arm. At the time of the report, the outcome of the events was unknown. The reporter considered the case as non-serious. Significant case correction received with IRD 06-Mar-2018: The as determined causality of all the events was corrected from unassessable to related. The co-suspect vaccine (PNEUMOVAX) was captured in case comment.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Headache, Injection site erythema, Injection site swelling, Insomnia, Pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709834), concerns a 68-year-old, elderly female patient. The patient's current illness and allergies were not reported. The patient's concomitant medications included LINZESS, simvastatin, bupropion, venlafaxine, trazodone, clonazepam. On 01-Aug-2017, the patient was administered with FLUAD (dose: 05 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178323, expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, batch number: N013521, dose, expiry date: not reported). On 23-Aug-2017, after 22 days of vaccination, the patient developed soreness in the arm. The arm was red and swollen around the injection site. The patient also had body aches, headaches and had trouble to sleep. Patient was advised to take TYLENOL and consult a physician if the symptoms did not improve. The outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received 06-Mar-2018: Case comment and narrative was corrected.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709834), concerns a 68-year-old, elderly female patient. The patient's current illness and allergies were not reported. The patient's concomitant medications included LINZESS, simvastatin, bupropion, venlafaxine, trazodone, clonazepam. On 01-Aug-2017, the patient was administered with FLUAD (dose: 05 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178323, expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, batch number: N013521, dose, expiry date: not reported). On 23-Aug-2017, after 22 days of vaccination, the patient developed soreness in the arm. The arm was red and swollen around the injection site. The patient also had body aches, headaches and had trouble to sleep. Patient was advised to take TYLENOL and consult a physician if the symptoms did not improve. The outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received 06-Mar-2018: Case comment and narrative was corrected.
Age: 71.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Head discomfort, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709836), concerning a 71-year-old, elderly female patient. The patient had a family history of stroke. The patient's current condition included: fibromyalgia. The patient had no known allergies. Concomitant medications: ELIQUIS, Metoprolol, Losartan, Econazole for an unknown indication. On 24-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N013521, dose, expiry date: not reported). On 25-Aug-2017, the patient developed soreness and redness of the arm. In addition, she had heavy headedness. Redness was noticed almost around the upper arm. The patient was advised to take TYLENOL for soreness and suggested to visit doctor if there was no improvement. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: Case comment was amended. No changes were made in the narrative.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Dyskinesia, Muscle twitching, Urticaria
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709911) concerns a 72-year-old, elderly, male patient. The patient's current conditions included hypertension, glaucoma, type 2 diabetes mellitus, degenerative discs (back pain). The patient's concomitant medications included allopurinol, vitamin C and D, lisinopril, amlodipine, omeprazole, simvastatin, atenolol/Chlorthalidone, alprazolam, Timolol eyedrops, UNISOM, CENTRUM SILVER vit. On 17-Aug-2017, the patient was administered with FLUAD (TIV) (dose:0.5, route of administration: intramuscular, anatomical location: left arm, batch number: 178502 and expiry date: not reported). On the same day after vaccination, the patient experienced a twitch in his legs and involuntarily the neck was turned. The patient also developed a few hives on his arm and toes. Reportedly, the patient had experienced twitches even after 48 hours of vaccination. The patient currently had hive on arm with no itcheds The outcome of the events (dyskinesia, muscle twitch and urticaria) was unknown and the event itch had recovered on an unspecified date. The reporter considered the case as non-serious. Non significant case correction received with IRD 06-Mar-2018: Case comment and event description of narrative was corrected.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Chills, Malaise, Pain, Pyrexia
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710061), concerns a 71-year-old, elderly, female patient. The patient had no historical condition. The patient's current condition included UTI (urinary tract infection). The patient had been allergic to MACRODANTIN and sulphur drugs. The patient's concomitant medication included AMOXI-CLAV tablets. On 04-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: injection, anatomical location: left arm, batch number: 178303 and expiry date: not reported). On 05-Aug-2017, after 1 day of vaccination, (reported as next morning), the patient experienced chills, body aches, and low-grade fever. It was reported that, the patient was sick for 1 day and no lab investigations were done. On an unspecified date in Aug-2017, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Chills, Pain in extremity, Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710268), concerns a 77-year-old elderly female patient. The patient's historical condition included kidney disease. The patient was allergic to clindamycin and opioids. On 22-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: right arm, batch number: 178323, route of administration and expiry date: not reported). On the same day, the patient was also administered PNEUMOVAX (anatomical location: left arm, batch number: N011305, dose: reported as 1, route of administration: unknown expiry date: not reported). On the same day, after the administration of vaccine, the patient experienced pain, swelling and heat after immunization in the left arm. It was reported that, patient also experienced chills and fever as well. At the time of this report, the patient had recovered from all the events. The reporter assessed this case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710399), concerns a 66-year-old, elderly female patient. The patient's concomitant medications included BONIVA, NAPROSYN, LIPITOR. On 24-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: unknown, anatomical location: left arm, batch number: 178503, expiry date: not reported) and PNEUMOVAX (anatomical location: left arm, batch number: M033086, dose: unknown, route of administration: unknown, expiry date: not reported). On 25-Aug-2017, next day of vaccination, the patient developed raised red bump on left arm approximately 2 inches from the site of vaccine administration. The patient was referred to the physician for consultation. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain in extremity, Rash
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710497), concerning a 71-year-old, elderly female patient. The patient's medical history and concomitant medications were not reported. On 10-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, batch number: 178502, anatomical location: left arm, expiry date: not reported). On 11-Aug-2017, after 1 day of vaccination, the patient had pain in arm which was more than 10 days and rash on the shoulder. The patient had recovered from all the events. The reporter assessed the events as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Chills, Hyperhidrosis, Immediate post-injection reaction, Lethargy, Malaise
Clinical narrative: This is a spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID; 710554), concerns a 77-year-old elderly female patient. The patient's historical conditions included atrial fibrillation, interstitial scarring and scoliosis. The patient had no known allergies. The patient's concomitant medications included PROTONIX, Bisoprolol, LIPITOR, Gabapentin, ELIQUIS, MULTAQ, CARTIA XT, Spironolactone, Torsemide, Prednisone decreasing dose (as reported), Magnesium, B12, IMMODIUM, Hair Skin Nails Vitamins, CITRICAL. On 11-Aug-2017, the patient was administered with FLUAD TIV (route of administration: injection (SYR as reported), anatomical location: left arm, batch number and expiry date: not reported). On 13-Aug-2017, after 3 days of vaccination, the patient did not feel well. Immediately following vaccination, the patient was lethargic and achy. On Tuesday, the patient had chills and woke up sweaty. It was reported that, multiple episodes of waking up with chills and sweaty were noted. The outcome of the events (chills, hyperhidrosis, immediate post-injection reaction, lethargy, malaise and pain) was recovered. The reporter assessed the case as non-serious. Significant case correction received with IRD 06-Mar-2018: The lethargy and pain were coded as the symptoms of immediate post injection reaction.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain
Clinical narrative: This is a spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID; 710554), concerns a 77-year-old elderly female patient. The patient's historical conditions included atrial fibrillation, interstitial scarring and scoliosis. The patient had no known allergies. The patient's concomitant medications included PROTONIX, Bisoprolol, LIPITOR, Gabapentin, ELIQUIS, MULTAQ, CARTIA XT, Spironolactone, Torsemide, Prednisone decreasing dose (as reported), Magnesium, B12, IMMODIUM, Hair Skin Nails Vitamins, CITRICAL. On 11-Aug-2017, the patient was administered with FLUAD TIV (route of administration: injection (SYR as reported), anatomical location: left arm, batch number and expiry date: not reported). On 13-Aug-2017, after 3 days of vaccination, the patient did not feel well. Immediately following vaccination, the patient was lethargic and achy. On Tuesday, the patient had chills and woke up sweaty. It was reported that, multiple episodes of waking up with chills and sweaty were noted. The outcome of the events (chills, hyperhidrosis, immediate post-injection reaction, lethargy, malaise and pain) was recovered. The reporter assessed the case as non-serious. Significant case correction received with IRD 06-Mar-2018: The lethargy and pain were coded as the symptoms of immediate post injection reaction.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Contusion, Immediate post-injection reaction, Swelling
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710947), concerns a 75-year-old, elderly, female patient. The patient's historical condition included hypothyroidism (unspecified date). The patient had no known allergy (NKA). The patient's current conditions were not reported. The patient's concomitant medication included ASA (acetylsalicylic acid) for an unknown indication. On 30-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178502, and expiry date: not reported. On the same day, immediately after the vaccination, the patient had swelling and bruising. At the time of this report, the patient had extensive bruising on arm of approximately 3 inches in diameter and had no pain. The patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Inflammation, Injection site erythema, Injection site nodule, Injection site reaction, Injection site swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710975), concerns a 68-year-old, elderly, female patient. On 29-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178502 and expiry date: not reported). On the same day, the patient was also administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N013521, dose, expiry date: not reported). On 30-Aug-2017, one day after vaccination, the patient had a knot form at the injection site which was red, swollen and had some splotches. It was reported that, the patient was advised to take ibuprofen for inflammation. The patient was advised to seek the medical treatment from urgent care or primary care physician if the condition worsen within a couple days. The outcome of the events was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The case comment was updated. No changes were made in narrative.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Rash macular
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 710975), concerns a 68-year-old, elderly, female patient. On 29-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178502 and expiry date: not reported). On the same day, the patient was also administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N013521, dose, expiry date: not reported). On 30-Aug-2017, one day after vaccination, the patient had a knot form at the injection site which was red, swollen and had some splotches. It was reported that, the patient was advised to take ibuprofen for inflammation. The patient was advised to seek the medical treatment from urgent care or primary care physician if the condition worsen within a couple days. The outcome of the events was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The case comment was updated. No changes were made in narrative.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Nausea, Peripheral swelling, Tenderness, Vomiting
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711009), concerns a 66-year-old, elderly female patient. On 01-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178323, expiry date: not reported) and PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: right arm, batch number: N013521, expiry date: not reported). On 09-Sep-2017, after 2 days of vaccination, the patient developed swollen right arm and was painful to touch. The patient also had nausea and vomiting. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site bruising, Injection site discolouration, Peripheral swelling
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711160), concerns an 82-year-old, elderly, female patient. The patient's medical history, allergy and concomitant medications were not reported. On 23-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, anatomical location: left arm, batch number: 178303, route of administration and expiry date: not reported) and non-company suspect product PNEUMOVAX (anatomical location: right arm, batch number: N010105, dose, route of administration and expiry date: not reported). On 24-Aug-2017, after 1 day of vaccination, the patient had arm swelling and her whole upper left arm was bruised and blue. At the time of this report, the outcome of the events was not reported. The reporter assessed the event as non-serious. Non-significant case correction received 06-Mar-2018: Case comment was amended. No changes were made in the narrative.
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711171), concerns a 81-year-old, elderly, male patient. On 30-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178503, expiry date: not reported). On the same day, the patient was also administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, dose: reported as 1, batch number: M018766, expiry date: not reported). On 31-Aug-2017, 1 day after vaccination, the patient developed redness, felt itching sensation on arm (reported as somewhat itchy) and his arm was swollen down to the elbow but not painful. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: Case comment was corrected.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Blood pressure increased, Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711368), concerns a 67-year-old elderly female patient. The patient's medical history included type II diabetes and high blood pressure. The patient's concomitant medications metformin, amlodipine, valsartan, krill fish oil (as reported), calcium, plant sterols and multivitamin. On 18-Aug-2017, the patient received FLUAD vaccine (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: 178502). On 18-Aug-2017, the patient received PNEUMOVAX (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: N004564). On the same day, after vaccine administration, the patient experienced localized reaction in left upper arm and swelling above the elbow with redness. It was reported that, the area was warm to touch, and pain limited the range of motion. The patient was advised to take TYLENOL, took BENADRYL on her own. The reaction resolved in 4-5 days. The outcome of all the events was recovered. The reporter assessed the case as non-serious. Non-significant case correction received with the IRD 06-Mar-2018: Treatment received was corrected from yes to unknown for the event local reaction. The narrative was corrected.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site warmth, Local reaction
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711368), concerns a 67-year-old elderly female patient. The patient's medical history included type II diabetes and high blood pressure. The patient's concomitant medications metformin, amlodipine, valsartan, krill fish oil (as reported), calcium, plant sterols and multivitamin. On 18-Aug-2017, the patient received FLUAD vaccine (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: 178502). On 18-Aug-2017, the patient received PNEUMOVAX (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: N004564). On the same day, after vaccine administration, the patient experienced localized reaction in left upper arm and swelling above the elbow with redness. It was reported that, the area was warm to touch, and pain limited the range of motion. The patient was advised to take TYLENOL, took BENADRYL on her own. The reaction resolved in 4-5 days. The outcome of all the events was recovered. The reporter assessed the case as non-serious. Non-significant case correction received with the IRD 06-Mar-2018: Treatment received was corrected from yes to unknown for the event local reaction. The narrative was corrected.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site pruritus, Local reaction, Vaccination site inflammation
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-MAR-2018 by Seqirus from VAERS (VAERS ID: 711452), concerns a 66-year-old, elderly, female patient. The patient's medical history was not reported. The patient's current condition included allergic fabric softener. The patient had no known drug and food allergy. The patient concomitant medication included aspirin. On 30-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5, route of administration: intramuscular, anatomical location: left arm, batch number: 178502 and expiry date: not reported) and PNEUMOVAX (dose: 0.5, route of administration: intramuscular, anatomical location: right arm, manufacturer, trade, batch number and expiry date: not reported). On the same day, after vaccination at evening, the patient experienced a localized reaction around the injection site on right arm after receiving the pneumococcal vaccine. It was reported that, the patient had soreness which limited range of motion and progressed to redness, inflammation and itchy circular area (3-4 inches in diameter) around the vaccination site and it was warm to touch. It was reported that, the events were resolved (2-3 days) from the onset date. At the time of this report, the outcome all the events had recovered. The reporter considered the case as non-serious. Non-significant case correction received on 06-Mar-2018: The case comment was updated. No changed were made in narrative.
Age: 66.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 06-MAR-2018 by Seqirus from VAERS (VAERS ID: 711452), concerns a 66-year-old, elderly, female patient. The patient's medical history was not reported. The patient's current condition included allergic fabric softener. The patient had no known drug and food allergy. The patient concomitant medication included aspirin. On 30-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5, route of administration: intramuscular, anatomical location: left arm, batch number: 178502 and expiry date: not reported) and PNEUMOVAX (dose: 0.5, route of administration: intramuscular, anatomical location: right arm, manufacturer, trade, batch number and expiry date: not reported). On the same day, after vaccination at evening, the patient experienced a localized reaction around the injection site on right arm after receiving the pneumococcal vaccine. It was reported that, the patient had soreness which limited range of motion and progressed to redness, inflammation and itchy circular area (3-4 inches in diameter) around the vaccination site and it was warm to touch. It was reported that, the events were resolved (2-3 days) from the onset date. At the time of this report, the outcome all the events had recovered. The reporter considered the case as non-serious. Non-significant case correction received on 06-Mar-2018: The case comment was updated. No changed were made in narrative.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Dizziness, Nausea
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711456), concerns a 66-year-old elderly female patient. On 01-Sep-2017 at 02:00hrs, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: unknown, anatomical location: left arm, batch number: 178601, expiry date: not reported). 02-Sep-2017 at 08:00hrs, after 1 day 6hrs of vaccination, the patient experienced nausea and dizziness. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Injection site rash, Injection site reaction, Injection site swelling, Injection site warmth, Rash macular
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711615), concerns a 76-year-old female patient. The patient's historical conditions included hypothyroidism, sensitivity to codeine and morphine. The patient's concomitant medications included Hydrochlorothiazide, LEVOTHROID, Gabapentin; Liothyronine, TYLENOL, Acetaminophen, Diclofenac sodium, Hydrocodone, Polyethylene glycol, Estriol and Omeprazole for an unknown indication. On 28-Aug-2017, the patient was administered with FLUAD (dose: 0.5ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 178323) and PREVNAR 13 (dose: reported as 2, route of administration: intramuscular, anatomical location: left arm, batch number: R49357). On an unspecified date, the patient developed swelling, rash, felt hot (reported as heat) and red splotches at the injection site. The outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: Case comment was corrected.
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising, Injection site swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711667), concerning a 67-year-old, adult female patient. The patient's medical history and concomitant medication were not reported. On 29-Aug-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178302A, expiry date: not reported). On 30-Aug-2017, after one day of vaccination, the patient developed bruising at injection site and the injection site area was raised. She was recommended to take BENADRYL (in case reaction was allergy) and was suggested to apply ice as needed to decrease swelling and bruising. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site swelling, Pain in extremity, Skin warm
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2017 by Seqirus from VAERS (VAERS ID: 711752), concerns a 77-year-old, elderly, female patient. The patient's historical condition included high cholesterol (unspecified date). The patient's current condition included high blood pressure (since an unspecified date). The patient had been allergic to penicillin. The patient's concomitant medications included lisinopril, ZETIA and Multivitamin. On 08-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179001 and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N005096, dose and expiry date: not reported). On the same day, approximately after 12 hours of vaccination, the patient had pain in arm which was hard to lift, hot to touch and developed red raised area near the injection site. It was reported that, it was noticed while laying on bed. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Neck pain, Nodule, Peripheral swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711755), concerns 72-year-old elderly female patient. The patient was allergic to hydrochlorothiazide and triamterene. On 08-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178323 and expiry date: not reported). On the same day, the patient was also administered with PNEUMOVAX (dose: (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: M042599 and expiry date: not reported). On 09-Sep-2017, 1 day after the administration of vaccine, the patient's left arm was red, swollen and a large knot was seen. It was reported that, the patient also experienced neck pain. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 80.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Feeling hot, Injection site induration, Pruritus, Swelling
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 711761), concerns 80-year-old elderly male patient. The patient's historical drugs included furosemide for edema, rosuvastatin for hypercholesterolemia, warfarin for anticoagulation, DIGITEK for heart failure and sertraline for mood (as reported). On 07-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178302A) and PNEUMOVAX (dose: 1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: M042599 and expiry date: not reported). On 08-Sep-2017, the patient started itching, felt warm, also had swelling, currently hard at injection site (as reported). All the information regarding the occurrence of events were reported by the patient's spouse. No idea on patient's lab data, but currently the patient action was unknown, recommended for a clinic visit for evaluation, possible antibiotic might be prescribed. The outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The case comment was corrected.
Age: 76.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Cough, Erythema, Pain in extremity, Peripheral swelling, Secretion discharge
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 712297), concerns a 76-year-old elderly female patient. On 10-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178303 and expiry date: not reported), on the same day, the patient was administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N010106, expiry date: not reported). On 11-Aug-2017, 1 day after vaccination, the patient experienced pain in arm, cough and developed mucous in chest. It was reported that, the arm was swollen and red. As the cough and mucous got worsen (reported as loud) after 2 weeks of vaccination. The patient went to emergency room and was treated with Azithromycin (250mg 2 tablets for 4 days). It was reported that, patient had still redness on face, under eyes. The patient recovered from the events. The reporter assessed this case as non-serious.
Age: 74.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 712376), concerns a 74-year-old female patient. The patient had no medical history and concomitant medications were unknown. On 11-Sep-2017, the patient was administered with FLUAD (dose 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number 178501) and PNEUMOVAX (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: M038216). On the same day, after vaccination, the patient had injection site reactions-pain, warmth, soreness, redness, swelling down to elbow. It was reported that, the patient injection site was hard (hardening as reported). At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received 06-Mar-2018: Case comment was corrected.
Sex: F
Vaccine: FLUX, FLU4, FLU4
Symptoms: Malaise, Myalgia
Clinical narrative: This non-serious case, reported by other non-health care professional to VAERS and initially retrieved, on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 712377), concerns a 24-year-old, adult, female patient. The patient's current conditions included asthma, ADHD (attention deficit/hyperactivity disorder) and allergic to walnuts, cats, sulfa drugs (causes rash) (since an unspecified dates). On an unspecified date in 2016, the patient was administered with Influenza (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date, the patient had malaise and myalgia. At the time of the report, the outcome of the events were not reported.
Sex: F
Vaccine: FLUX, FLU4, FLU4
Symptoms: Asthenia, Asthma, Chest discomfort, Chills, Condition aggravated
Clinical narrative: This non-serious case, reported by other non-health care professional to VAERS and initially retrieved, on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 712377), concerns a 24-year-old, adult, female patient. The patient's current conditions included asthma, ADHD (attention deficit/hyperactivity disorder) and allergic to walnuts, cats, sulfa drugs (causes rash) (since an unspecified dates). On an unspecified date in 2016, the patient was administered with Influenza (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date, the patient had malaise and myalgia. At the time of the report, the outcome of the events were not reported.
Sex: F
Vaccine: FLUX, FLU4, FLU4
Symptoms: Discomfort, Dyspnoea, Headache, Heart rate increased, Hyperhidrosis
Clinical narrative: This non-serious case, reported by other non-health care professional to VAERS and initially retrieved, on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 712377), concerns a 24-year-old, adult, female patient. The patient's current conditions included asthma, ADHD (attention deficit/hyperactivity disorder) and allergic to walnuts, cats, sulfa drugs (causes rash) (since an unspecified dates). On an unspecified date in 2016, the patient was administered with Influenza (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date, the patient had malaise and myalgia. At the time of the report, the outcome of the events were not reported.
Sex: F
Vaccine: FLUX, FLU4, FLU4
Symptoms: Malaise, Muscle spasms, Myalgia, Nausea, Pain
Clinical narrative: This non-serious case, reported by other non-health care professional to VAERS and initially retrieved, on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 712377), concerns a 24-year-old, adult, female patient. The patient's current conditions included asthma, ADHD (attention deficit/hyperactivity disorder) and allergic to walnuts, cats, sulfa drugs (causes rash) (since an unspecified dates). On an unspecified date in 2016, the patient was administered with Influenza (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date, the patient had malaise and myalgia. At the time of the report, the outcome of the events were not reported.
Sex: F
Vaccine: FLUX, FLU4, FLU4
Symptoms: Pyrexia
Clinical narrative: This non-serious case, reported by other non-health care professional to VAERS and initially retrieved, on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 712377), concerns a 24-year-old, adult, female patient. The patient's current conditions included asthma, ADHD (attention deficit/hyperactivity disorder) and allergic to walnuts, cats, sulfa drugs (causes rash) (since an unspecified dates). On an unspecified date in 2016, the patient was administered with Influenza (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date, the patient had malaise and myalgia. At the time of the report, the outcome of the events were not reported.
Age: 75.0
Sex: M
Vaccine: FLUA3
Symptoms: Depression, Tearfulness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713022), concerning a 75-year-old, elderly male patient. The patient's historical condition included: chronic kidney disease. The patient was allergic to sulfa antibiotic. Concomitant medications included: HCTZ, Losartan, Potassium, Amlodipine, LUNESTA, PROSCAR and Lorazepam for an unknown indication. On 13-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location, left arm, route of administration, batch number, expiry date: not reported). On 15-Sep-2017, after 2 days of vaccination, the patient had sudden onset of depression and tearfulness. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 68.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713042), concerns a 68-year-old, elderly, male patient. The patient's historical condition and concomitant medication were not reported. The patient had no current condition. The patient was allergic to penicillin and cephalosporin. On 15-Sep-2017, the patent was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, batch number: 178802, anatomical location and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, batch number; S31255, dose, anatomical location and expiry date: not reported). On the same day, after few hours of vaccination, the patient had swelling in arm like size of a softball (as reported) and pain in arm. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 70.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Chills, Diarrhoea, Peripheral swelling, Pyrexia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713052) concerns a 70-year-old elderly female patient. The patient was allergic to azithromycin, sulfa and penicillin. On 14-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported), and also administered with PREVENAR 13, dose: (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: R70446 and expiry date: not reported). On 15-Sep-2017, 1 day after vaccination, the patient experienced swelling of right arm, which was about the softball size. The patient also experienced fever, chills, diarrhoea. It was reported that, swelling was improved over 2 days but was still present. The outcome of the event swollen arm was recovering and outcome of the events fever, chills, and diarrhoea was unknown. The reporter assessed this case as non-serious.